RATIO-TOPISALIC LOTION

Kraj: Kanada

Język: angielski

Źródło: Health Canada

Składnik aktywny:

BETAMETHASONE (BETAMETHASONE DIPROPIONATE); SALICYLIC ACID

Dostępny od:

TEVA CANADA LIMITED

Kod ATC:

D07XC01

INN (International Nazwa):

BETAMETHASONE

Dawkowanie:

0.5MG; 20MG

Forma farmaceutyczna:

LOTION

Skład:

BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5MG; SALICYLIC ACID 20MG

Droga podania:

TOPICAL

Sztuk w opakowaniu:

30ML/60ML

Typ recepty:

Prescription

Dziedzina terapeutyczna:

ANTI-INFLAMMATORY AGENTS

Podsumowanie produktu:

Active ingredient group (AIG) number: 0215695003; AHFS:

Status autoryzacji:

APPROVED

Data autoryzacji:

2013-02-22

Charakterystyka produktu

_ _
_ratio-TOPISALIC Lotion (Betamethasone Dipropionate and Salicylic
Acid) _
_ _
_Page 1 of 20_
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
RATIO-TOPISALIC
Betamethasone Dipropionate (0.5 mg / g as base)
and Salicylic Acid (20 mg / g)
LOTION
TOPICAL CORTICOSTEROID AND KERATOLYTIC
TEVA CANADA LIMITED
Date of Revision:
30 Novopharm Court
April 17, 2020
Toronto, Ontario,
Canada M1B 2K9
www.tevacanada.com
Submission Control No: 235690
_ _
_ratio-TOPISALIC Lotion (Betamethasone Dipropionate and Salicylic
Acid) _
_ _
_Page 2 of 20_
TABLE OF CONTENTS
TABLE OF CONTENTS
.............................................................................................................
2
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
1
INDICATIONS
.................................................................................................................
3
1.1
Pediatrics
...................................................................................................................
3
1.2
Geriatrics
...................................................................................................................
3
2
CONTRAINDICATIONS
................................................................................................
3
3
DOSAGE AND ADMINISTRATION
............................................................................
3
3.1
Dosing Considerations
..............................................................................................
3
3.2
Recommended Dose and Dosage Adjustment
.......................................................... 4
4
MISSED DOSE
.................................................................................................................
4
5
OVERDOSAGE
................................................................................................................
4
6
DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING .............. 4
7
WARNINGS AND PRECAUTIONS
..............................................